Delivery Order SPE2DB22D2005-SPE2DB25FJRG0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $3,132.07 under firm fixed price terms. The delivery order is not set-aside and represents a competitively awarded procurement. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $10,741.92 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $47,007.95. This is a firm fixed-price delivery order with no set-aside designation, placing performance at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 10 mg/ml in ampule form, with a contract ceiling value of $2,026.26 and an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is valued at $5,659.98 and is for the delivery of the pharmaceutical product phytonadione 1 mg/0.5 mL syringe, 0.5 mL. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,289.64, is for the delivery of 4,567,442,998 units of the medication phytonadione 1 mg/0.5 ml syringe. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency awarded a delivery order valued at $8,308.92 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on September 17, 2025, with completion targeted for September 18, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Phytonadione 1 mg/0.5 ml syrup, a specialty pharmaceutical product. The contract has a ceiling value of $7,889.06 and an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The $3,679.40 contract is for the supply of phytonadione 1 mg/0.5 ml syrups. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRG0Delivery Order
The Defense Logistics Agency awarded a $3,214.86 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Phytonadione 1 mg/0.5 ml syringes in 0.5 ml quantities, with final delivery due by August 12, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a critical vendor for federal medical procurement, AmerisourceBergen has demonstrated capability to meet federal requirements across multiple therapeutic domains, with contract awards reflecting consistent delivery of both brand-name and generic pharmaceuticals to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/11/25 |